Law360 has named Skadden M&A partner Nancy Lieberman among its 2012 "M&A MVPs" (Dec. 4). The publication noted that her lead role in helping Amylin Pharmaceutical's extricate itself from litigation and completing a $7 billion sale to Bristol-Myers Squibb Co. "highlighted a banner year" for Ms. Lieberman.
Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates